Jason Beaubien

Jason Beaubien is NPR's Global Health and Development Correspondent on the Science Desk.

In this role, he reports on a range of issues across the world. He's covered the plight of Rohingya refugees in Bangladesh, mass cataract surgeries in Ethiopia, abortion in El Salvador, poisonous gold mines in Nigeria, drug-resistant malaria in Myanmar and tuberculosis in Tajikistan. He was part of a team of reporters at NPR that won a Peabody Award in 2015 for their extensive coverage of the West Africa Ebola outbreak. His current beat also examines development issues including why Niger has the highest birth rate in the world, can private schools serve some of the poorest kids on the planet and the links between obesity and economic growth.

Prior to becoming the Global Health and Development Correspondent in 2012, Beaubien spent four years based in Mexico City covering Mexico, Central America and the Caribbean. In that role, Beaubien filed stories on politics in Cuba, the 2010 Haitian earthquake, the FMLN victory in El Salvador, the world's richest man and Mexico's brutal drug war.

For his first multi-part series as the Mexico City correspondent, Beaubien drove the length of the U.S./Mexico border making a point to touch his toes in both oceans. The stories chronicled the economic, social and political changes along the violent frontier.

In 2002, Beaubien joined NPR after volunteering to cover a coup attempt in the Ivory Coast. Over the next four years, Beaubien worked as a foreign correspondent in sub-Saharan Africa, visiting 27 countries on the continent. His reporting ranged from poverty on the world's poorest continent, the HIV in the epicenter of the epidemic, and the all-night a cappella contests in South Africa, to Afro-pop stars in Nigeria and a trial of white mercenaries in Equatorial Guinea.

During this time, he covered the famines and wars of Africa, as well as inspiring preachers and Nobel laureates. Beaubien was one of the first journalists to report on the huge exodus of people out of Sudan's Darfur region into Chad, as villagers fled some of the initial attacks by the Janjawid. He reported extensively on the steady deterioration of Zimbabwe and still has a collection of worthless Zimbabwean currency.

In 2006, Beaubien was awarded a Knight-Wallace fellowship at the University of Michigan to study the relationship between the developed and the developing world.

Beaubien grew up in Maine, started his radio career as an intern at NPR Member Station KQED in San Francisco and worked at WBUR in Boston before joining NPR.

Two teams of European scientists, working independently, say they believe they've identified the cause of a rare blood clotting condition that has occurred in some people after receiving the AstraZeneca COVID-19 vaccine.

If correct, their research could mean any blood clots that occur could be easily treated.

There were reports earlier this month of roughly 30 blood clots occurring after vaccination, a few of them fatal. This led more than a dozen European countries to suspend their use of the AstraZeneca vaccine.

For anyone looking forward to the annual frivolity of spring break or the diversion offered every year by March Madness, the coronavirus pandemic is once again reminding: not so fast.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

A MARTINEZ, HOST:

The Biden administration says it plans to send millions of doses of the AstraZeneca COVID-19 vaccine to Canada and Mexico. That vaccine isn't yet authorized for use here in the U.S. Here's White House press secretary Jen Psaki.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

A MARTINEZ, HOST:

Editor's note: This story was updated at 9:55 a.m. ET on Feb. 20 to include a statement provided by email from AstraZeneca.

The Prime Minister of Trinidad and Tobago, Keith Rowley, is not happy about how the global rollout of COVID vaccines is going. He's not happy at all.

"We are more than a little bit concerned that there is ... or is to be ... hoarding and price gouging," of vaccines, the Prime Minister said in a press conference on Thursday with the head of the World Health Organization.

In some countries, citizens are grumbling about the inefficient rollout of COVID-19 vaccines. It's unclear exactly when doses will be available. Websites for appointments keep crashing. Lines are long.

And then there are the 130 countries that "are yet to administer a single dose," according to UNICEF. That's 2.5 billion people who so far have been completely shut out of the global vaccine campaign.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

SCOTT SIMON, HOST:

The World Health Organization says countries should move forward with using the Oxford/AstraZeneca COVID vaccine even in places with variant strains of the virus.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

MARY LOUISE KELLY, HOST:

Peru is scrambling to get access to COVID vaccines as cases spike.

But the Latin American nation is in a tough slot.

The first problem is its relative wealth. Peru is classified by the World Bank as "upper middle-income." So it has some money to spend on vaccines but not nearly the financial resources of the U.S., the European Union or even wealthier neighbors like Brazil or Chile. But it's not poor enough to qualify for free doses from COVAX, the global program aimed at assuring equitable access to vaccines.

Aid agencies report swarms of locusts have been descending on farms in northern Kenya, destroying crops and even leaving pastures bare of vegetation.

The UN's Food and Agriculture Organization in a regional update on the pests says swarms have been detected this week in seven counties in Kenya compared to just four a week ago.

Across the Horn of Africa locust invasions have reached dangerous levels in Ethiopia, Somalia and Kenya, according to the FAO.

The New York Mets have fired the team's new general manager Jared Porter over alleged sexual harassment of a female reporter.

Guatemala security forces are attempting to block thousands of Honduran migrants from heading north towards Mexico and the U.S. border.

On Sunday, police and soldiers in riot gear confronted a caravan of migrants from Honduras on a highway near Chiquimula in southeastern Guatemala. After a tense standoff, in which police fired tear gas and attempted to beat back the migrants with batons, the surging crowd broke through a phalanx of soldiers.

As nations around the world scramble to start vaccinating against COVID-19, many countries are finding it difficult if not impossible to get the vaccines they want.

Case in point — Argentina. President Alberto Fernández promised to start vaccination campaigns in the South American nation before the end of 2020.

Even disaster experts are stunned by the devastation this fall in Honduras.

"I've been to too many disasters all over the world," says Vlatko Uzevski, who arrived in Honduras last week from Macedonia to lead an emergency response team for Project Hope.

"And I have never been to a place that was struck by two hurricanes in two weeks," says Uzevski, a physician who has been doing this type of work for 15 years.

Coronary heart disease and stroke are the two leading causes of death for Homo sapiens on planet Earth, according to a new report from the World Health Organization. This fact has remained unchanged for the past two decades. But this analysis of global deaths over the past 20 years finds significant shifts in how people die — as well as dramatic differences in what leads to death in different regions.

Noncommunicable diseases such as dementia and diabetes are now claiming more lives, while infectious diseases such as HIV and tuberculosis are taking far fewer.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

DAVID GREENE, HOST:

A once-promising treatment against COVID-19 has fallen out of favor with the World Health Organization.

On Thursday, a WHO review panel issued new guidelines recommending against the use of remdesivir for COVID-19 — even though the medicine is one of the few to win regulatory approval as a treatment for the disease.

Steven used to take a pill every morning to control his HIV. Then he heard about a study for a ground-breaking treatment where he wouldn't have to take any pills at all.

"I get an injection in each butt cheek once a month," says Steven, an attorney based in Pittsburgh, Pa., who tested positive in 2015.

He's asked us to withhold his last name because while he came out as gay last year, he hasn't come out to all his professional contacts.

The drug he's getting is called Cabenuva. It's one of a new type of anti-AIDS drugs that need to be taken only a few times a year.

While an effective vaccine against HIV may still be a long way off, a new HIV prevention technique has proven remarkably effective at protecting women against the virus.

A single injection of a drug called cabotegravir every two months was so successful in preventing HIV in a clinical trial among women in sub-Saharan Africa that the study was wrapped up ahead of schedule.

The multibillion-dollar global effort to eradicate polio hasn't just stalled. It's moving backward.

When the Global Polio Eradication Initiative began in 1988, roughly 350,000 kids a year were paralyzed by the virus. By 2016 that number had been driven down to 42 cases of any type of polio anywhere in the world.

During this pandemic, people in the United States are dying at rates unparalleled elsewhere in the world.

A new report in the Journal of the American Medical Association finds that in the past five months, per capita deaths in the U.S., both from COVID-19 and other causes, have been far greater than in 18 other high-income countries.

"It's shocking. It's horrible," says Dr. Ezekiel J. Emanuel, a professor of health policy and medical ethics at the University of Pennsylvania and one of the authors of the study.

In March, Dr. Achintya Moulick found himself at the epicenter of the U.S. coronavirus pandemic.

He oversees three CarePoint Health hospitals in northern New Jersey and in the early days of the pandemic, they were swamped. "We had no idea what this infection was all about," he says.

One of the first challenges was screening patients for COVID-19 even before they entered the hospital.

"One day I saw a big line outside the entrance of the hospital," he says. "And they were manually checking everybody's temperature."

This year's Nobel Peace Prize has been given to the U.N. World Food Programme for its efforts to fight hunger and to prevent the use of starvation as a weapon of war.

But did you know that the World Food Programme has a canine mascot named Foxtrot?

Copyright 2020 NPR. To see more, visit https://www.npr.org.

MARY LOUISE KELLY, HOST:

About 10% of the global population may have been infected by the coronavirus, according to a senior World Health Organization official.

It's an estimate that's far higher than the total of global confirmed cases reported by governments. At the same time, it would mean that most of the world's population is still vulnerable to getting infected and this pandemic is far from over, the WHO's head of emergencies Dr. Michael Ryan said Monday.

The United States is home to the world's best-known technology companies, but so far the use of smartphones to fight the coronavirus has been tepid at best.

Smartphones have the potential to be a powerful tool in tracking the spread of COVID-19. They can tell you exactly how close you've been to other people, for how long and keep a detailed log of everyone you've been around for the last 14 days. Linked to testing systems, they can rapidly alert you if someone you've been in contact with tests positive.

Copyright 2020 NPR. To see more, visit https://www.npr.org.

SACHA PFEIFFER, HOST:

As millions of students return to virtual classes at their dining room tables, some parents who are also trying to work from home have decided to ship their kids off to camp.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

STEVE INSKEEP, HOST:

Pages